Saitoh, Akihiko <br/><br/>
Efavirenz pharmacokinetics in HIV-1-infected children are associated with CYP2B6-G516T polymorphism.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Jul 2007 
 - 280-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1525-4135 
<br/><br/><label>Standard No.: </label>10.1097/QAI.0b013e318040b29e  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alkynes<br/>Anti-HIV Agents--pharmacokinetics<br/>Antiretroviral Therapy, Highly Active<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Benzoxazines--pharmacokinetics<br/>Child<br/>Child, Preschool<br/>Cyclopropanes<br/>Cytochrome P-450 CYP2B6<br/>Drug Resistance, Viral<br/>Female<br/>Genotype<br/>HIV Infections--drug therapy<br/>HIV-1--drug effects<br/>Humans<br/>Male<br/>Oxidoreductases, N-Demethylating--genetics<br/>Polymorphism, Genetic--genetics